PURPOSE: Although numerous publications have described distraction osteogenesis (DO) for craniosynostosis, methods of reporting quantitative results have been inconsistent. Therefore, the efficacy of anterior DO and posterior DO in regards to volume change is not well established. We report a metric that relates volume change to distraction length and our analysis of ICV change by distraction osteogenesis.
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METHODS:
Patients with craniosynostosis were treated with open cranial vault reconstruction combined with internal distraction. Preoperative and postoperative CT scans were used to quantify ICV change. Our metric was calculated by dividing percent ICV change by total distraction length. Multiple linear regression was used to identify the impact of distraction approach (anterior vs. posterior), age, time between CT scans, distraction length, and preoperative volume on ICV change. Additionally, we compared our findings to those reported in the literature.
RESULTS:
Nine unicoronal craniosynostosis patients underwent anterior distraction. Three bicoronal patients and 1 multisutural patient underwent posterior distraction. The average ICV increase was 1.6% per millimeter of distraction for anterior DO compared to 4.2% for posterior DO (p<0.05). On multiple regression, preoperative volume was negatively associated with percent volume change (p<0.05). Posterior approach was positively associated with percent volume change (p<0.05). The volume-length relations from institutional data were greater than those derived from the literature, but not statistically significant.
CONCLUSION:
We report relations between distraction length and intracranial volume change for posterior and anterior DO and a comparison to the literature. Additionally, we describe a novel metric for analyzing ICV change achieved by DO. PURPOSE: Enhanced Recovery After Surgery pathway (ERAS) was introduced in 1997 as a multimodal approach to improve postoperative preventable harm and to shorten hospital length of stay (LOS). However, there is yet no widely accepted ERAS for microsurgical breast reconstruction (MBR). This study aims to conduct a systematic review and a meta-analysis of the current literature on ERAS for MBR in regards to postoperative LOS and morbidity.
19.

ENHANCED RECOVERY AFTER SURGERY PATHWAY FOR MICROSURGICAL BREAST
METHODS:
We searched PubMed, Embase, Cochrane, Scopus and Web of Science for all studies published prior to June 2016 that contain original data investigating ERAS in MBR in relation to postoperative LOS and morbidity. Studies found were screened using eligibility criteria previously agreed upon. Meta-analysis, odds ratio and 95% confidence interval were used to pool acquired data.
RESULTS:
The initial search identified 87 studies. Two independent screeners identified four original articles, with a pooled population of 676 patients. ERAS LOS was reported in three studies to be lower when compared to the previous protocols, from 6.6 to 3.9 days (p<0.001), 7.4 to 6.2 days (p<0.001), and 6.2 to 3.1 days (p<0.001).Two studies were pooled for the meta-analysis of postoperative morbidity, which suggested that ERAS was not associated with changes in 30 days postoperative morbidity; partial flap loss (p=0.44), total flap loss (p=0.91), breast hematoma
